Job Opportunities API

About us Hansa Biopharma is a fast-growing, commercial-stage biopharmaceutical company, pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with acute or complex immune disorders. Our broad therapeutic pipeline based on the company’s proprietary IgG-cleaving enzyme technology platform has potential to address serious unmet medical needs in autoimmune diseases, gene therapy, and transplantation. By empowering our people we move our projects forward with high speed, efficiency and scientific excellence. We strive to attract leading talent from around the world, broaden our network of partners and establish a presence in key markets around the world. There are many opportunities for highly qualified, motivated, and passionate team players to join us on our exciting journey. Hansa Biopharma was founded in 2007, with the corporate headquarters in Lund, Sweden and has operations in other European countries and in the US. The Company has been listed on the Nasdaq First North Growth Market Stockholm from 2007 to 2015 and on the Nasdaq Stockholm since 2015. Position summary : Associate Director / Director, US Policy and Patient Advocacy Associate Director/Director of US Policy and Patient Advocacy play a pivotal role on the Global Corporate Affairs team at Hansa set and deliver the company’s US policy and patient advocacy engagement strategy aligned with our corporate objectives and in rare immunological diseases business. As part of the Global Corporate Affairs team, this role is responsible for analyzing the US policy and healthcare environment to identify opportunities and challenges impacting Hansa. The position develops and drives an actionable policy strategy, working closely with US Market Access and cross‑functional teams to support sustainable patient access to innovative therapies in rare disease. The role leads engagement with Patient Advocacy Groups (PAGs) relevant to Hansa’s therapeutic areas, building trusted relationships and structured collaboration plans. Through policy and patient advocacy initiatives, the role supports patient access, engagement, and collaboration across relevant parts of the healthcare ecosystem. The role will serve as a bridge between patient organizations, and Hansa, working closely with US Patient Marketing, and ensuring that patient perspectives are reflected in relevant decision-making. The individual in this role will report to the VP, Corporate Affairs. This position will be hybrid and based in Hansa’s NYC office and requires regular on-site presence, once the NYC office (Manhattan) is established. Key tasks and responsibilities This job description outlines key responsibilities but does not include all potential tasks or duties. Analyze the US healthcare policy and external environment to identify opportunities and risks impacting Hansa’s commercial and clinical‑stage programs. Develop and execute a US policy and environment‑shaping plan to support commercialization planning and product launches in the US by ensuring policy and patient advocacy considerations are integrated early and effectively. Collaborate closely with cross‑functional teams (Global Corporate Affairs, Market Access, Commercial, Medical Affairs, R&D) to deliver on agreed policy and patient advocacy priorities. Build and maintain strategic relationships with policy makers, public health decisionmakers, and patient advocacy groups to advance Hansa’s policy and patient engagement agenda. Strategically identify and engage key Patient Advocacy Groups at US, national, and state levels, defining priority programs and partnership opportunities aligned with therapeutic areas. Act as a trusted collaboration partner to Patient Advocacy Groups, supporting patient access, engagement, and education initiatives where appropriate and compliant. Clearly and impactfully communicate Hansa’s p